These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38110967)

  • 1. Political Economy of Non-Communicable Disease (NCD) prevention and control in Lebanon: identifying challenges and opportunities for policy change and care provision reforms.
    Bou-Orm IR; Loffreda G; Diaconu K; Witter S; deVos P
    BMC Public Health; 2023 Dec; 23(1):2526. PubMed ID: 38110967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya.
    Shiroya V; Neuhann F; Müller O; Deckert A
    Glob Health Action; 2019; 12(1):1611243. PubMed ID: 31117896
    [No Abstract]   [Full Text] [Related]  

  • 3. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.
    Milsom P; Smith R; Baker P; Walls H
    Global Health; 2021 Nov; 17(1):134. PubMed ID: 34819083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
    Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
    Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and Opportunities for WHO "Best Buys" Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review.
    Loffreda G; Arakelyan S; Bou-Orm I; Holmer H; Allen LN; Witter S; Ager A; Diaconu K
    Int J Health Policy Manag; 2024; 13():7989. PubMed ID: 38618832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
    Suzuki M; Webb D; Small R
    Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Public Policies to Address Non-communicable Diseases in the Caribbean Country of Barbados: The Importance of Problem Framing and Policy Entrepreneurs.
    Unwin N; Samuels TA; Hassell T; Brownson RC; Guell C
    Int J Health Policy Manag; 2017 Feb; 6(2):71-82. PubMed ID: 28812782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges for delivering non-communicable disease management and services in fragile and post-conflict settings: perceptions of policy-makers and health providers in Sierra Leone.
    Witter S; Zou G; Diaconu K; Senesi RGB; Idriss A; Walley J; Wurie HR
    Confl Health; 2020; 14():3. PubMed ID: 31921333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and non-communicable diseases in Mexico: a political mapping and stakeholder analysis.
    Orozco-Núñez E; Ojeda-Arroyo E; Cerecer-Ortiz N; Guerrero-López CM; Ramírez-Pérez BM; Heredia-Pi I; Allen-Leigh B; Feeny E; Serván-Mori E
    Health Res Policy Syst; 2024 Apr; 22(1):46. PubMed ID: 38605301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare system responses to non-communicable diseases' needs of Syrian refugees: The cases of Jordan and Lebanon.
    Akik C; Asfahani F; Elghossain T; Mesmar S; Rabkin M; El Sadr W; Fouad FM; Ghattas H
    J Migr Health; 2022; 6():100136. PubMed ID: 36148323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges in implementing non-communicable disease policies in Sudan.
    Elhadi YAM
    Health Res Policy Syst; 2023 Dec; 21(1):130. PubMed ID: 38057882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The process of prioritization of non-communicable diseases in the global health policy arena.
    Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
    Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of non-communicable diseases policies in post-apartheid South Africa.
    Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
    Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
    BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening Sugar-Sweetened Beverage Taxation for Non-Communicable Disease Prevention: A Comparative Political Economy Analysis Case Study of Fiji and Tonga.
    Mounsey S; Vaka AK; Cama T; Waqa G; McKenzie B; Thow AM
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health reform in Nigeria: the politics of primary health care and universal health coverage.
    Croke K; Ogbuoji O
    Health Policy Plan; 2024 Jan; 39(1):22-31. PubMed ID: 37978878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.